Zobrazeno 1 - 10
of 236
pro vyhledávání: '"Shuichi Miyawaki"'
Autor:
Saiko Kurosawa, Shuichi Miyawaki, Takuhiro Yamaguchi, Heiwa Kanamori, Toru Sakura, Yukiyoshi Moriuchi, Fumiaki Sano, Takeshi Kobayashi, Atsushi Yasumoto, Kazuo Hatanaka, Masamitsu Yanada, Yuichiro Nawa, Jin Takeuchi, Yukinori Nakamura, Shin Fujisawa, Hirohiko Shibayama, Ikuo Miura, Takahiro Fukuda
Publikováno v:
Haematologica, Vol 98, Iss 10 (2013)
Core binding factor acute myeloid leukemia is known to have a favorable prognosis, however, there have been no detailed analyses on prognostic factors after first relapse. Using a nationwide database, we retrospectively analyzed core binding factor a
Externí odkaz:
https://doaj.org/article/4fce2915197c4bc7b218045aed1ad13a
Autor:
Saiko Kurosawa, Takuhiro Yamaguchi, Shuichi Miyawaki, Naoyuki Uchida, Toru Sakura, Heiwa Kanamori, Kensuke Usuki, Takuya Yamashita, Yasushi Okoshi, Hirohiko Shibayama, Hirohisa Nakamae, Momoko Mawatari, Kazuo Hatanaka, Kazutaka Sunami, Manabu Shimoyama, Naohito Fujishima, Yoshinobu Maeda, Ikuo Miura, Yoichi Takaue, Takahiro Fukuda
Publikováno v:
Haematologica, Vol 95, Iss 11 (2010)
Background Patients with acute myeloid leukemia who are treated with conventional chemotherapy still have a substantial risk of relapse; the prognostic factors and optimal treatments after relapse have not been fully established. We, therefore, retro
Externí odkaz:
https://doaj.org/article/2b4b19720230449bba867998468f4a6d
Autor:
Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura, Hideki Akiyama, Noriko Usui, Fumiharu Yagasaki, Kazuhiro Nishii, Yasunori Ueda, Makoto Takeuchi, Shuichi Miyawaki, Atsuo Maruta, Hiroto Narimatsu, Yasushi Miyazaki, Shigeki Ohtake, Itsuro Jinnai, Keitaro Matsuo, Tomoki Naoe, Ryuzo Ohno
Publikováno v:
Haematologica, Vol 93, Iss 2 (2008)
To identify factors associated with relapse-free survival (RFS), 80 patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia, enrolled in a phase II study of imatinib-combined chemotherapy, were analyzed. The median
Externí odkaz:
https://doaj.org/article/5e4b4da313874836a8be830d424b4481
Autor:
Seishi Ogawa, Hideki Makishima, Akifumi Takaori-Kondo, Lee-Yung Shih, Felicitas Thol, Michael Heuser, Arnold Ganser, Kazuma Ohyashiki, Takayuki Ishikawa, Jaroslaw P. Maciejewski, Shuichi Miyawaki, Hisashi Tsurumi, Nobuo Sezaki, Kensuke Usuki, Toshiyuki Kitano, Yasushi Miyazaki, Shigeru Chiba, Satoru Miyano, Ken Ishiyama, Hideyuki Nakazawa, Akira Hangaishi, Nobuhiro Hiramoto, Daisuke Morishita, Yasunobu Nagata, Cassandra M. Kerr, Ming-Chung Kuo, Yuichi Shiraishi, Hiroko Tanaka, Kenichi Chiba, Ayana Kon, Takuto Mori, Xingxing Qi, Rurika Okuda, Lanying Zhao, Yotaro Ochi, Ryunosuke Saiki, Akinori Yoda, Yasuhito Nannya, Masahiro M. Nakagawa, Kenichi Yoshida, June Takeda
Acute erythroid leukemia (AEL) is a unique subtype of acute myeloid leukemia characterized by prominent erythroid proliferation whose molecular basis is poorly understood. To elucidate the underlying mechanism of erythroid proliferation, we analyzed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44a93ec3045451fa3ff7b29a983e4abd
https://doi.org/10.1158/2643-3230.c.6550902.v1
https://doi.org/10.1158/2643-3230.c.6550902.v1
Autor:
Seishi Ogawa, Hideki Makishima, Akifumi Takaori-Kondo, Lee-Yung Shih, Felicitas Thol, Michael Heuser, Arnold Ganser, Kazuma Ohyashiki, Takayuki Ishikawa, Jaroslaw P. Maciejewski, Shuichi Miyawaki, Hisashi Tsurumi, Nobuo Sezaki, Kensuke Usuki, Toshiyuki Kitano, Yasushi Miyazaki, Shigeru Chiba, Satoru Miyano, Ken Ishiyama, Hideyuki Nakazawa, Akira Hangaishi, Nobuhiro Hiramoto, Daisuke Morishita, Yasunobu Nagata, Cassandra M. Kerr, Ming-Chung Kuo, Yuichi Shiraishi, Hiroko Tanaka, Kenichi Chiba, Ayana Kon, Takuto Mori, Xingxing Qi, Rurika Okuda, Lanying Zhao, Yotaro Ochi, Ryunosuke Saiki, Akinori Yoda, Yasuhito Nannya, Masahiro M. Nakagawa, Kenichi Yoshida, June Takeda
Supplementary Figure from Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9319fb1c74d5594ca439a7f9481dc60d
https://doi.org/10.1158/2643-3230.22545315
https://doi.org/10.1158/2643-3230.22545315
Autor:
Seishi Ogawa, Hideki Makishima, Akifumi Takaori-Kondo, Lee-Yung Shih, Felicitas Thol, Michael Heuser, Arnold Ganser, Kazuma Ohyashiki, Takayuki Ishikawa, Jaroslaw P. Maciejewski, Shuichi Miyawaki, Hisashi Tsurumi, Nobuo Sezaki, Kensuke Usuki, Toshiyuki Kitano, Yasushi Miyazaki, Shigeru Chiba, Satoru Miyano, Ken Ishiyama, Hideyuki Nakazawa, Akira Hangaishi, Nobuhiro Hiramoto, Daisuke Morishita, Yasunobu Nagata, Cassandra M. Kerr, Ming-Chung Kuo, Yuichi Shiraishi, Hiroko Tanaka, Kenichi Chiba, Ayana Kon, Takuto Mori, Xingxing Qi, Rurika Okuda, Lanying Zhao, Yotaro Ochi, Ryunosuke Saiki, Akinori Yoda, Yasuhito Nannya, Masahiro M. Nakagawa, Kenichi Yoshida, June Takeda
Supplementary Table from Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a1b0b535b90c3612802e56e3a46929d
https://doi.org/10.1158/2643-3230.22545312
https://doi.org/10.1158/2643-3230.22545312
Autor:
Mikiko Kusano, Shin ichiro Fujiwara, Takayuki Shimizu, Masahiro Kizaki, Junya Kuroda, Kensuke Usuki, Erhan Berrak, Miho Nara, Shuichi Miyawaki, Tomoki Naoe, Kiyoshi Ando, Yoshinobu Maeda, Nobuyuki Aotsuka, Nahla Hasabou, Yukio Kobayashi, Qiaoyang Lu, Takayuki Ishikawa, Hisayuki Yokoyama, Tomoko Hata, Shigeru Chiba, Naoko Hosono, Masahiro Onozawa, Kohmei Kubo, Michihiro Hidaka, Yasuyoshi Morita, Hiroatsu Iida
Publikováno v:
International Journal of Clinical Oncology
Background Until recently, no effective targeted therapies for FLT3-mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML) were available in Japan. The FLT3 inhibitor, gilteritinib, was approved in Japan for patients with FLT3mut+
Autor:
Yuki Shukuya, Hideharu Muto, Ryosuke Konuma, Yuya Kishida, Tatsuya Konishi, Satoshi Kaito, Shuichi Miyawaki, Junji Tomiyama
Publikováno v:
Nihon Naika Gakkai Zasshi. 110:613-621
Autor:
June Takeda, Kenichi Yoshida, Masahiro M. Nakagawa, Yasuhito Nannya, Akinori Yoda, Ryunosuke Saiki, Yotaro Ochi, Lanying Zhao, Rurika Okuda, Xingxing Qi, Takuto Mori, Ayana Kon, Kenichi Chiba, Hiroko Tanaka, Yuichi Shiraishi, Ming-Chung Kuo, Cassandra M. Kerr, Yasunobu Nagata, Daisuke Morishita, Nobuhiro Hiramoto, Akira Hangaishi, Hideyuki Nakazawa, Ken Ishiyama, Satoru Miyano, Shigeru Chiba, Yasushi Miyazaki, Toshiyuki Kitano, Kensuke Usuki, Nobuo Sezaki, Hisashi Tsurumi, Shuichi Miyawaki, Jaroslaw P. Maciejewski, Takayuki Ishikawa, Kazuma Ohyashiki, Arnold Ganser, Michael Heuser, Felicitas Thol, Lee-Yung Shih, Akifumi Takaori-Kondo, Hideki Makishima, Seishi Ogawa
Publikováno v:
Blood cancer discovery. 3(5)
Acute erythroid leukemia (AEL) is a unique subtype of acute myeloid leukemia characterized by prominent erythroid proliferation whose molecular basis is poorly understood. To elucidate the underlying mechanism of erythroid proliferation, we analyzed
Autor:
Fumihiro Ishida, Norio Komatsu, Yasuhiko Kano, Kazuhiro Nishii, Sumihisa Honda, Akihiro Takeshita, Shinichiro Machida, Michinori Ogura, Takeshi Morii, Takahiro Yamauchi, Tomoki Naoe, Kazunori Ohnishi, Nahoko Hatsumi, Noriko Usui, Yukihiro Arai, Shuichi Miyawaki
Publikováno v:
International Journal of Hematology. 109:418-425
Given the poor prognosis of patients with relapsed/refractory acute myeloid leukemia (AML), better therapy is needed. Fludarabine enhances the efficacy of Ara-C (cytarabine) by increasing intracellular Ara-C-triphosphate. The FLAG (fludarabine, high-